26 June 2008
| Pharmaceuticals:
Generic pharmaceuticals are enjoying a dream run in worldwide pharmaceutical markets as strong competition to branded pharmaceuticals. The forces at work are similar across the globe - increasing healthcare costs and aging populations. If initiatives from European governments are creating one set of opportunities for generics manufacturers, developments in the overall pharmaceutical market are creating another. Here, on one hand, a number of blockbuster drugs are expected to go off patent. Even with heavy price erosion due to intense competition, this is expected to create an immense opportunity for generics manufacturers.
29 May 2008
| Drug Discovery:
Several procedures such as culture techniques, Immunoassays/Serology and Fluorescent In Situ Hybridisation (FISH) have been used to detect disease agents for many years. However amplification technologies such as polymerase chain reaction (PCR) have been shown to be very popular amongst end users and are creating a great amount of interest in the market place.
15 May 2008
| Healthcare Technology:
For many years, Anaesthesia has served the function of enabling surgeons and clinicians to perform invasive procedures without letting the patient experience any pain. However, with the growing number of complex surgical procedures being performed worldwide, the vast field of anaesthesia is also observing sea changes, both in terms of emerging technologies and market dynamics.
22 April 2008
| Genomics:
Results from a recent study, aimed at testing the hypothesis that migrations within historical times could have contributed to the Y-chromosomal (male) genetic diversity in modern day Lebanon, have revealed the legacies left behind by these travellers.
14 April 2008
| Office Applications:
Big pharma companies, big lay-offs and big biotech deals. Stakeholders will be smiling as the pharma giants roll up their sleeves to set things right. While many consider the recent trend a knee-jerk reaction to declining profits and drug failures, people who pull the strings in these companies have a different view of the situation. Rising healthcare expenditures has been a major concern to the European governments. While price regulations and generic manufacturers are doing a great job in reducing the costs for the government, the companies developing drugs have not helped themselves.
17 March 2008
| Healthcare:
There are about 1.8 million people worldwide living with non-Hodgkin’s lymphoma (NHL). It is the sixth most common form of cancer in Europe. The disease is complicated in nature with about 25-30 sub types. Its incidence in Europe varies from 4 to 14 for every 100,000 people. In the European Union alone approximately 50,000 new cases are diagnosed each year. The risk of developing the disease increases with age, especially among the 55-85 year group. The incidence rate peaks between the ages of 75 and 85 years. With rising life expectancy levels across Europe, the demand for NHL drugs is set to grow.
04 March 2008
| Medical Imaging:
MRI systems represent one of the strongest markets in the medical imaging industry. MRI is a non-invasive method of using a magnetic field and radio waves to create detailed images of the inside of the human body. It was originally used to view the central nervous system. With time, its use has expanded to study the internal anatomical structures of the human body.
13 February 2008
| Industry Analysis:
The saga to bring to life - efficiency, absolute patient safety, and cost-effectiveness continues. The United Kingdom decided to take proactive steps to overhaul its health systems by introducing new infrastructure and healthcare technology solutions. The process involved partnering with large systems integrators on a journey that has been envisaged to culminate with health professionals and staff maximizing limited resources and providing the highest levels of care to the aging British population.
07 January 2008
| Life Science Computing:
As I approach my thirtieth year of life I look back with fond memories of weekends spent round a friends house playing our way through the bunch of games rented from the local video store. If my friends suggestion of a fun weekend had been along the lines of “fancy coming over to use some software I have leased for defined amount of time for a specific unit cost” I would probably have gone to play football with someone else.
04 December 2007
| In-vitro Diagnostics:
In vitro diagnostics (IVD) involves diagnosing and analyzing the pathological condition of diseases and plays a major role in clinical decisions. The diagnostics market involves two different types of testing methods: In vivo and In vitro diagnostics. In vivo diagnostics involves imaging technology like X-rays, CT scans, MRI and nuclear imaging. In vitro diagnostics involves testing patient’s body fluids, tissue samples. Both these markets have traditionally been independent of each other. Over the past few years, however, synergies between the two have been highly evident, as aptly demonstrated by the entrance of GE Healthcare and Siemens Medical Solutions Diagnostics.
|
|
|
|
